| |
| |
|
| Insider
Information: |
Tahl Cindy |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
142,361 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$526,736 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
142,361 |
|
|
| Total
Value |
$526,736 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
6
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -185.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Fate Therapeutics Inc |
FATE |
|
2024-01-09 |
142,361 |
2015-10-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2024-01-09 |
4 |
S |
$4.37 |
$47,519 |
D/D |
(10,874) |
142,361 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2023-11-09 |
4 |
AS |
$2.40 |
$58,471 |
D/D |
(24,363) |
153,235 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2023-01-10 |
4 |
S |
$5.24 |
$60,538 |
D/D |
(11,553) |
177,598 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2022-06-01 |
4 |
AS |
$22.96 |
$574,000 |
D/D |
(25,000) |
189,151 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2022-06-01 |
4 |
OE |
$6.55 |
$163,750 |
D/D |
25,000 |
214,151 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2022-04-01 |
4 |
OE |
$4.84 |
$130,520 |
D/D |
25,000 |
214,151 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2022-04-01 |
4 |
AS |
$38.85 |
$971,250 |
D/D |
(25,000) |
189,151 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
See Remarks |
• – – |
2022-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
33,302 |
189,151 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2022-01-11 |
4 |
S |
$48.46 |
$262,975 |
D/D |
(5,419) |
155,849 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2022-01-10 |
4 |
S |
$46.37 |
$359,313 |
D/D |
(7,738) |
161,268 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2022-01-03 |
4 |
AS |
$57.76 |
$2,966,853 |
D/D |
(50,000) |
169,006 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2022-01-03 |
4 |
OE |
$6.55 |
$327,500 |
D/D |
50,000 |
219,006 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2021-10-01 |
4 |
AS |
$58.03 |
$2,941,462 |
D/D |
(50,000) |
108,048 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2021-10-01 |
4 |
OE |
$6.55 |
$327,500 |
D/D |
50,000 |
158,048 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2021-07-01 |
4 |
AS |
$84.56 |
$4,733,743 |
D/D |
(55,534) |
108,048 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2021-07-01 |
4 |
OE |
$4.84 |
$313,242 |
D/D |
55,534 |
163,582 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
See Remarks |
• – – |
2021-04-01 |
4 |
AS |
$80.49 |
$2,514,329 |
D/D |
(30,000) |
108,048 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
See Remarks |
• – – |
2021-04-01 |
4 |
OE |
$2.90 |
$96,199 |
D/D |
30,000 |
138,048 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2021-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
18,013 |
108,048 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2021-01-19 |
4 |
AS |
$114.11 |
$4,016,639 |
D/D |
(35,000) |
90,035 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2021-01-19 |
4 |
OE |
$2.90 |
$101,500 |
D/D |
35,000 |
125,035 |
0 |
- |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2021-01-11 |
4 |
S |
$109.65 |
$360,587 |
D/D |
(3,254) |
90,035 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2021-01-08 |
4 |
S |
$114.76 |
$729,434 |
D/D |
(6,229) |
93,289 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2020-11-05 |
4 |
AS |
$50.55 |
$976,252 |
D/D |
(19,282) |
99,518 |
0 |
% |
|
| FATE |
Fate Therapeutics Inc |
General Counsel and Secretary |
• – – |
2020-11-05 |
4 |
OE |
$2.73 |
$54,340 |
D/D |
19,282 |
118,800 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
